Although double blind randomized controlled trials (DBRCTs) are considered the gold standard in evaluating a drug or therapy, it may be time for a new model, according to researchers. They say that DBRCTs don’t factor in patient behaviors, such as diet and lifestyle choices, that can affect the drug or treatment being tested. A recent… Continue reading Developing Better Clinical Trials